Both in Diagnostics
Intellia Therapeutics vs Celldex Therapeutics
Over the past year NTLA returned −28.9% and CLDX returned +20.8%; their daily moves had a correlation of 0.26.
NTLA −28.9% CLDX +20.8%Growth of $1, one year, split-adjusted
| Metric | NTLA | CLDX |
|---|---|---|
| Price | $12.03 | $31.64 |
| Market cap | $1.69B | $2.48B |
| Today | +5.34% | +0.48% |
| 1 month | −6.5% | −19.1% |
| 6 months | +3.3% | +7.3% |
| Year to date | +33.8% | +16.5% |
| 1 year | −26.2% | +21.0% |
| Revenue growth (YoY) | −46.2% | −97.0% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1392.3% | −334104.5% |
| P/E (TTM) | — | — |
| Price / sales | 28.3× | 15,725.8× |
| Net cash | $437.8M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 64.4% | 47.6% |
| Short % of float | 40.7% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).